Indication: Used to treat the following infectious diseases of moderate severity or above caused by sensitive strains: 1. Acute exacerbation of chronic bronchitis: caused by Streptococcus pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis or Staphylococcus aureus. 2. Acute sinusitis: caused by Streptococcus pneumoniae and Haemophilus influenzae. 3. Community-acquired pneumonia: caused by Streptococcus pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, Staphylococcus aureus, Chlamydia pneumophila, Mycoplasma pneumophila or Legionella pneumophila. 4. Simple or complicated urinary tract infection (cystitis): caused by Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, etc. 5. Pyelonephritis: caused by Escherichia coli, etc. 6. Simple urethral and cervical gonorrhea: caused by Neisseria gonorrhoeae. 7. Acute simple rectal infection in women: caused by Neisseria gonorrhoeae. Before treatment, appropriate culture and sensitivity tests should be performed to isolate and identify the pathogenic microorganisms and determine their sensitivity to gatifloxacin. However, treatment with this product can be started before the results of the bacteriological examination are obtained. After the results of the bacteriological examination are obtained, appropriate treatment can be continued.

Indication: Used for symptoms such as fever, headache, nasal congestion, runny nose, sore throat, body aches, etc. caused by colds, acute rhinitis, acute sinusitis, etc.

Indication: Used for symptoms such as fever, headache, nasal congestion, runny nose, sore throat, body aches, etc. caused by colds, acute rhinitis, acute sinusitis, etc.

Indication: Used for symptoms such as fever, headache, nasal congestion, runny nose, sore throat, body aches, etc. caused by colds, acute rhinitis, acute sinusitis, etc.

Indication: Used for symptoms such as fever, headache, nasal congestion, runny nose, sore throat, body aches, etc. caused by colds, acute rhinitis, acute sinusitis, etc.

Indication: Used for the following mild and moderate infections caused by sensitive bacteria: 1. Upper respiratory tract infections ⑴ Streptococcus pyogenes pharyngitis/tonsillitis. Note: Intramuscular penicillin should usually be used to treat and prevent streptococcal infections (including prevention of rheumatic fever). Although cefuroxime can generally effectively eliminate Streptococcus pyogenes in the nasopharynx, there is currently no reference data on the use of cefuroxime to prevent secondary rheumatic fever. ⑵ Otitis media and acute sinusitis caused by Streptococcus pneumoniae, Haemophilus influenzae (including B-lactamase-producing strains) and Moraxella catarrhalis (including B-lactamase-producing strains). 2. Lower respiratory tract infections caused by Streptococcus pneumoniae, Haemophilus influenzae

Indication: It is used for the following mild and moderate infections caused by sensitive bacteria: upper respiratory tract infections (pyogenic streptococcal pharyngitis/tonsillitis, otitis media, acute sinusitis), lower respiratory tract infections (acute bronchitis secondary to bacterial infection and acute exacerbation of chronic bronchitis), skin and soft tissue infections.

Indication: For mild and moderate infections caused by sensitive bacteria. Upper respiratory tract infection, purulent streptococcal pharyngitis/tonsillitis. Note: Intramuscular penicillin should be selected for the treatment and prevention of streptococcal infections (including the prevention of rheumatic fever). Although cefprozil is generally effective in clearing purulent streptococci in the nasopharynx, there is currently no data available for the use of cefprozil in the prevention of secondary rheumatic fever. Otitis media caused by Streptococcus pneumoniae, Haemophilus influenzae (including β-lactamase-producing strains), and Moraxella catarrhalis (including β-lactamase-producing strains). Acute sinusitis caused by Streptococcus pneumoniae, Haemophilus influenzae (including β-lactamase-producing strains), and Moraxella catarrhalis (including β-lactamase-producing strains). Lower respiratory tract infection, secondary bacterial infection of acute bronchitis and acute exacerbation of chronic bronchitis caused by Streptococcus pneumoniae, Haemophilus influenzae (including β-lactamase-producing strains), and Moraxella catarrhalis (including β-lactamase-producing strains). Skin and skin tissue infections caused by Staphylococcus aureus (including penicillinase-producing strains) and Streptococcus pyogenes are uncomplicated, but abscesses usually require surgical drainage.

Indication: It is used for the following mild and moderate infections caused by sensitive bacteria: 1. Upper respiratory tract infection. 2. Lower respiratory tract infection. 3. Skin and skin soft tissue infection.

Indication: It is used for the following mild and moderate infections caused by sensitive bacteria: 1. Upper respiratory tract infection. 2. Lower respiratory tract infection. 3. Skin and skin soft tissue infection.